Expression of collagenases (matrix metalloproteinase-1, 8, 13) and tissue inhibitor of metalloproteinase-1 of retrodiscal tissue in temporomandibular joint disorder patients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The aim of this study was to reveal how collagenases (matrix metalloproteinase [MMP]-1, 8, 13) and tissue inhibitor of metalloproteinase 1 (TIMP-1) are expressed in immunohistochemistry of retrodiscal tissue in temporomandibular joint disorder patients. Materials and Methods: This study was conducted on 39 patients who underwent discoplasty or discectomy. Immunohistochemical staining was undertaken and expression levels of MMP-1, 8, 13, and TIMP-1 were evaluated. The status of internal derangement of disc, osteoarthritis, and joint effusion were analyzed using magnetic resonance imaging (MRI). Disc status observed during operation was also categorized. Results: The more severe disc derangement was observed on MRI, the more increased expression of MMPs and TIMP-1 appeared. Regarding MMP-13 expression, 86.7% of late-stage disc displacement patients showed grade II or III. Expression level of MMPs or TIMP was not statistically significant associated with joint effusion level. In perforation and/or adhesion groups, all patients showed grade II or III expression of MMP-13. Once perforation occurred, MMP-13 showed increased expression with statistical significance.Conclusion: MMP-1 and MMP-13 expression seem to be related to progression of osteoarthritis whereas MMP-8 does not seem to have a specific role with regard to temporomandibular joint disorders. TIMP-1 is considered to be partly related to internal derangement rather than osteoarthritis, but it is not significant.
Abstract
Objectives: The aim of this study was to reveal how collagenases (matrix metalloproteinase [MMP]-1, 8, 13) and tissue inhibitor of metalloproteinase 1 (TIMP-1) are expressed in immunohistochemistry of retrodiscal tissue in temporomandibular joint disorder patients. Materials and Methods: This study was conducted on 39 patients who underwent discoplasty or discectomy. Immunohistochemical staining was undertaken and expression levels of MMP-1, 8, 13, and TIMP-1 were evaluated. The status of internal derangement of disc, osteoarthritis, and joint effusion were analyzed using magnetic resonance imaging (MRI). Disc status observed during operation was also categorized. Results: The more severe disc derangement was observed on MRI, the more increased expression of MMPs and TIMP-1 appeared. Regarding MMP-13 expression, 86.7% of late-stage disc displacement patients showed grade II or III. Expression level of MMPs or TIMP was not statistically significant associated with joint effusion level. In perforation and/or adhesion groups, all patients showed grade II or III expression of MMP-13. Once perforation occurred, MMP-13 showed increased expression with statistical significance.Conclusion: MMP-1 and MMP-13 expression seem to be related to progression of osteoarthritis whereas MMP-8 does not seem to have a specific role with regard to temporomandibular joint disorders. TIMP-1 is considered to be partly related to internal derangement rather than osteoarthritis, but it is not significant.
참고문헌 (28)
- Ishibashi H, "Expression of extracellular matrix in human mandibular condyle", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 81, pp.402~414 (1996)[DOI]
- Kapila S, "Characterization and identification of proteinases and proteinase inhibitors synthesized by temporomandibular joint disc cells", J Dent Res, 74, pp.1328~1336 (1995)[DOI]
- Vaatainen U, "Markers of cartilage and synovial metabolism in joint fluid and serum of patients with chondromalacia of the patella", Osteoarthritis Cartilage, 6, pp.115~124 (1998)[DOI]
- Kubota E, "Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease", J Oral Maxillofac Surg, 56, pp.192~198 (1998)[DOI]
- Imai K, "Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage", Am J Pathol, 151, pp.245~256 (1997)
- Imai S, "High levels of expression of collagenase-3 (MMP-13) in pathological conditions associated with a foreign-body reaction", J Bone Joint Surg Br, 80, pp.701~710 (1998)[DOI]
- Kubota E, "Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint", J Oral Maxillofac Surg, 55, pp.20~27 (1997)[DOI]
- Tiilikainen P, "MMP-3 and -8 expression is found in the condylar surface of temporomandibular joints with internal derangement", J Oral Pathol Med, 34, pp.39~45 (2005)[DOI]
- Huh JK, "Magnetic resonance imaging of temporomandibular joint synovial fluid collection and disk morphology", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 95, pp.665~671 (2003)[DOI]
- McDonnell S, "Role of matrix metalloproteinases in normal and disease processes", Biochem Soc Trans, 27, pp.734~740 (1999)[DOI]
- Mizui T, "Matrix metalloproteinase-2 in synovial lavage fluid of patients with disorders of the temporomandibular joint", Br J Oral Maxillofac Surg, 39, pp.310~314 (2001)[DOI]
- Dioszegi M, "Vertebrate collagenases", Methods Enzymol, 248, pp.413~431 (1995)
- Jeffrey JJ, "Matrix metalloproteinases" (1998), Academic Press
- Freije JM, "Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas", J Biol Chem, 269, pp.16766~16773 (1994)
- Reboul P, "The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis", J Clin Invest, 97, pp.2011~2019 (1996)[DOI]
- Mitchell PG, "Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage", J Clin Invest, 97, pp.761~768 (1996)[DOI]
- Hasty KA, "The collagen substrate specificity of human neutrophil collagenase", J Biol Chem, 262, pp.10048~10052 (1987)
- Welgus HG, "The collagen substrate specificity of human skin fibroblast collagenase", J Biol Chem, 256, pp.9511~9515 (1981)
- Gepstein A, "Expression of matrix metalloproteinases in articular cartilage of temporomandibular and knee joints of mice during growth, maturation, and aging", Arthritis Rheum, 46, pp.3240~3250 (2002)[DOI]
- Gepstein A, "Association of metalloproteinases, tissue inhibitors of matrix metalloproteinases, and proteoglycans with development, aging, and osteoarthritis processes in mouse temporomandibular joint", Histochem Cell Biol, 120, pp.23~32 (2003)[DOI]
- 허종기, "측두하악 관절원판 후조직의 MMP(matrix metalloproteninase)-1과 MMP-2 Mrna의 발현", 대한구강악안면외과학회지, 29(4), pp.212~218 (2003), 대한구강악안면외과학회
- Ishimaru JI, "Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and lavage synovial fluid of patients with temporomandibular joint disorders", Br J Oral Maxillofac Surg, 38, pp.354~359 (2000)[DOI]
- Leonardi R, "MMP-13 (collagenase 3) localization in human temporomandibular joint discs with internal derangement", Acta Histochem, 110, pp.314~318 (2008)[DOI]
- Marchetti C, "Immunolocalization of gelatinase-A (matrix metalloproteinase-2) in damaged human temporomandibular joint discs", Arch Oral Biol, 44, pp.297~304 (1999)[DOI]
- Gomis-Ruth FX, "Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1", Nature, 389, pp.77~81 (1997)[DOI]
- Naito K, "Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis", Rheumatology (Oxford), 38, pp.510~515 (1999)[DOI]
- Wang YL, "Matrix metalloproteinase and its inhibitor in temporomandibular joint osteoarthrosis after indirect trauma in young goats", Br J Oral Maxillofac Surg, 46, pp.192~197 (2008)[DOI]
- Sawatsubashi M, "Expression of MMP-1, TIMP-1, and type I collagen in laryngeal carcinoma", Mod Pathol, 11, pp.878~885 (1998)